Market Place
Sourcing Support
All News #Library
Biotech
Ironwood Pharma To Present HCP Views On Tpn Impact In (SBS)
23 Apr 2026 //
PHARMIWEB
Ironwood Maintains FY 2025 Financial Guidance
02 Jan 2026 //
BUSINESSWIRE
Ironwood Pharma Boosts 2025 Financial Outlook
10 Nov 2025 //
BUSINESS WIRE
Ironwood Pharmaceuticals Updates on Apraglutide Clinical Trials
14 Apr 2025 //
BUSINESSWIRE
Ironwood Receives Notification Regarding Late 2024 Form 10-K Filing
27 Mar 2025 //
BUSINESSWIRE
Ironwood Pharma Reports Q4 and Full Year 2024 Results
27 Feb 2025 //
BUSINESSWIRE
Ironwood Submits Apraglutide NDA, Updates Corporate Structure
29 Jan 2025 //
BUSINESSWIRE
Ironwood to Participate in Jefferies London Health Conference
13 Nov 2024 //
BUSINESSWIRE
Ironwood makes bid for $1B GI drug with subgroup data
29 Oct 2024 //
FIERCE BIOTECH
Ironwood Presents Apraglutide SBS-IF Data At DDW Late-Breaker
21 May 2024 //
BUSINESSWIRE
Ironwood: Apraglutide SBS-IF Data At DDW 2024
01 May 2024 //
BUSINESSWIRE
Ironwood Results from Ph II Trial of Apraglutide in Patients with SR GI aGVHD
28 Mar 2024 //
BUSINESSWIRE
Ironwood Announces Positive Results from Phase III of Once-Weekly Apraglutide
29 Feb 2024 //
BUSINESSWIRE
Ironwood Announces Publication of Linaclotide Phase III Data
08 Jan 2024 //
BUSINESSWIRE
Ironwood Presents New Data on Potential Linaclotide for Functional in Children
08 May 2023 //
BUSINESSWIRE
Ironwood to Present New Data at Digestive Disease Week® 2023 of Linaclotide
24 Apr 2023 //
BUSINESSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.